CAAS Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-20,000
| Closed | -$204K | – | 531 |
|
|
2022
Q4 | $204K | Sell |
20,000
-65,851
| -77% | -$670K | 0.01% | 322 |
|
|
2022
Q3 | $213K | Sell |
85,851
-11,661
| -12% | -$28.9K | 0.01% | 315 |
|
|
2022
Q2 | $242K | Buy |
97,512
+11,661
| +14% | +$28.9K | 0.01% | 292 |
|
|
2022
Q1 | $255K | Hold |
85,851
| – | – | 0.01% | 179 |
|
|
2021
Q4 | $607K | Hold |
85,851
| – | – | 0.01% | 209 |
|
|
2021
Q3 | $895K | Buy |
85,851
+65,404
| +320% | +$682K | 0.02% | 256 |
|
|
2021
Q2 | $251K | Sell |
20,447
-329,553
| -94% | -$4.05M | ﹤0.01% | 513 |
|
|
2021
Q1 | $7.7M | Buy |
+350,000
| New | +$7.7M | 0.08% | 110 |
|